Remedy Robotics

Remedy Robotics develops robotic systems for endovascular intervention. Its N1 system is built for remote neurovascular and cardiovascular procedures, giving clinicians robotic control for catheter-based treatment of stroke, aneurysm, bleeding and other vascular conditions.

Facts

Segment: Surgical
Country: United States
Founded: 2020
Website: https://www.remedyrobotics.com

Funding

2025-10-06 - Series A - $35M - Remedy Robotics raises $35M Series A to scale remote surgical robotics platform - source: axios.com

View funding

Investors

Blackbird Ventures - Lead - VC - 1 funding event - first seen 2025-10-06
DCVC - Lead - VC - 1 funding event - first seen 2025-10-06

View investors

Supply

Hydrix - Inbound - Robotics Compute Software - Hydrix develops safety-critical software and electronics for the N1 surgical robot - source: announcements.asx.com.au

View supply

Timeline

2025-10-06 - Product Launch - Remedy Robotics Introduces N1 System, Completes First Fully Remote Neurointerventional Procedures - • Remedy Robotics introduced the N1 System, a remotely operable endovascular robotic platform. • Dr. Vitor Mendes Pereira performed the world's first fully remote neurointerventional procedures using the N1 System between St. Michael'... • These procedures… - source: remedyrobotics.com
2025-10-01 - Deployment - Doctors in Toronto complete distant brain angiograms using the N1 system from Remedy Robotics - Remedy Robotics completed the world's first fully remote neurointerventional procedures using the N1 System. Dr. Vitor Mendes Pereira performed these procedures remotely from St. Joseph's Health Centre on patients located at St. Michael's Hospital in… - source: remedyrobotics.com

View timeline

Team

David Bell - Co-Founder and CEO

View team